Purui Shunxiang Completes Tens of Millions of RMB Series A Funding to Accelerate Innovation in Domestic High-End Minimally Invasive Surgical Instruments

VCBeat has learned that, recently, a leading domestic supplier of minimally invasive surgical instrument productsSichuan Purui Shunxiang Medical Devices Co.,LtdSuccessfully ObtainedBeijing E-town International Investment&DevelopmentTens of millions of yuan in Series A investment, with the financial advisor for this financing transaction beingMedBio Capitalserve in this capacity. This collaboration will inject strong momentum into Sichuan Purui Shunxiang Medical Devices Co.,Ltd.'s continuous innovation and market expansion in the medical device sector.

The Purui Shunxiang team has been deeply engaged in the medical device industry for many years. Its founder, Zou Jianlong, previously built Anhe Jialier into China’s top domestic ultrasonic scalpel brand and successfully executed its acquisition and sale. Leveraging years of technological accumulation and the translation of clinical achievements, the company has establishedTrauma Surgery, Energy-based Surgery, Electronic Endoscopes, High-value Consumables, and CDMOFive Core Technology Platforms, Rich Product Matrix, CoveringSuperSuction Knife, Radiofrequency Plasma, Ultrasonic Scalpel System, Urological Surgery Consumables Series, Endoscopic Surgery System, Nerve Conduitamong other varieties, it has obtained more than 30 medical device registration certificates both domestically and internationally.

2024 marked the company’s inaugural year of commercialization, with multiple innovative products already adopted for clinical use at numerous top-tier tertiary hospitals across China, earning unanimous acclaim from clinical experts.

Guided by clinical needs, the company remains committed to technological innovation, ensuring that product iterations keep pace with medical advancements. It has achieved significant results in addressing clinical challenges, providing not only stable and reliable products for established surgical procedures but also developing innovative devices for advanced techniques. Its technical prowess and product quality have earned recognition from industry leaders.

Beijing E-town International Investment&Development, as the investor in this round, has expressed strong confidence in Sichuan Purui Shunxiang Medical Devices Co.,Ltd. The company’s diversified technology platforms and product pipeline, along with its outstanding performance in the process of domestic substitution, align closely with the investment strategy of Beijing E-town International Investment&Development. Through this investment, Beijing E-town International Investment&Development aims to help Sichuan Purui Shunxiang further expand production scale, enhance R&D capabilities, accelerate the innovative development of high-end domestically produced minimally invasive surgical instruments, and promote the upgrading of the regional healthcare industry.